Run time: 13m

To view this video content in its entirety, click on the "Access Content" button and login to your account.

If you do not have an account, register for free.


Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual events.


On Demand

Shared H3.3 K27M Mutation Is Recognized as a Neoantigen by Specific TCRs and Leads to Upregulation of PD-L1 on Glioma Cells [POSTER PRESENTATION]

Free

Description

Recorded during the Keystone Symposia meeting:

Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology

Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Speaker(s):

  • Hideho Okada, MD, PhD, University of California San Francisco
Tags: SciTalk cancer

You must be logged in and own this session in order to post comments.